TickerFactsScreenerDevelopers

Niagen Bioscience, Inc. (NAGE) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2010: $1.05M2011: $2.56M2012: $3.99M2013: $5.67M2015: $4.00M2016: $9.97M2017: $53.83M2018: $27.18M2019: $20.45M2020: $16.42M2021: $31.73M2022: $28.67M2023: $28.46M2024: $46.09M2025: $76.53M$76.53M
2010Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$76.53M+66.0%
2024$46.09M+62.0%
2023$28.46M-0.8%
2022$28.67M-9.6%
2021$31.73M+93.2%
2020$16.42M-19.7%
2019$20.45M-24.8%
2018$27.18M-49.5%
2017$53.83M+439.7%
2016$9.97M+149.5%
2015$4.00M—
2013$5.67M+41.9%
2012$3.99M+55.9%
2011$2.56M+144.5%
2010$1.05M—